SAN DIEGO--(BUSINESS WIRE)--Mentor Capital, Inc. (OTC Markets: MNTR) is initiating the repurchase of 300,000 shares of its currently outstanding common stock. The repurchase will be funded by the commitment of approximately 5% of the company’s cash and cash-like current assets which are specifically identified and reserved. Mentor Capital’s first stock repurchase plan of 100,000 shares was fully executed and completed in December 2013. It is the company’s policy to fully execute any stock repurchase plan announced.
In analyzing the stock repurchase decision, Mentor Capital notes that the company is cash and current asset rich with virtually no non-affiliate debt in a market expected to grow twenty-fold. In this upward trending sector, Mentor Capital will invest in cannabis companies with greater promise as it rotates out of other cannabis companies with less potential, all in the normal course. The company CEO has sold no shares.
Stock repurchases are intended to be conducted in compliance with the Rule 10b-18 safe harbor guidelines
About Mentor Capital: By acquisition or stock purchase, Mentor Capital, Inc. seeks to invest in leading cannabis companies. Additional important information for investors and founders seeking expansion funding is presented at: www.MentorCapital.com
This press release is neither an offer to sell, nor a solicitation of offers to purchase, securities.
Forward Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as “should,” “could,” “expects,” “may,” or “intends,” and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales activities, problems securing the necessary financing to continue operations, problems encountered in commercializing cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, difficulties in recruiting knowledgeable and potential problems in protecting intellectual property. Further information concerning these and other risks is included in the Company’s 15c2-11 filing which, along with other very important information about the Company, can be found here:
The Company undertakes no obligation to update or revise such forward-looking statements to reflect events or circumstances occurring after the date of this press release.